問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

朱士傑
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2013-04-01 - 2022-12-05

Phase IV

A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, AutoantibodyPositive Systemic Lupus Erythematosus Receiving Belimumab
  • Condition/Disease

    Systemic Lupus Erythematosus

  • Test Drug

    BENLYSTA (Belimumab)

Participate Sites
8Sites

Recruiting1Sites

Terminated7Sites